GC
DSCI

Guggenheim Capital’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Guggenheim Capital’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-11,145
Closed -$129K – 3312
2014
Q2 		$129K Sell
11,145
-678
-6% -$6.96K ﹤0.01% 2972
2014
Q1 		$149K Buy
+11,823
New +$153K ﹤0.01% 2951

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Guggenheim Capital's DSCI Position: Q3 2014 in Review

Guggenheim Capital sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q3 2014, closing a stake of 11,145 shares — an estimated $129K sold.

Guggenheim Capital first reported a position in DSCI in Q1 2014 and held it in 2 quarters. The position peaked at $149K in Q1 2014. 70 funds tracked by Wall St. Rank hold DSCI as of Q3 2014.

  • Guggenheim Capital reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q3 2014 after selling out during the quarter.
  • Guggenheim Capital sold 11,145 Derma Sciences, Inc. Common Stock (DE) shares in Q3 2014, an estimated $129K.
  • Guggenheim Capital first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 2 quarters.
  • Guggenheim Capital's Derma Sciences, Inc. Common Stock (DE) position peaked at $149K in Q1 2014.
  • 70 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q3 2014.

Based on Guggenheim Capital's 13F filing for Q3 2014, filed 14 Nov 2014.